BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1281 related articles for article (PubMed ID: 26571451)

  • 41. High versus low-added sugar consumption for the primary prevention of cardiovascular disease.
    Bergwall S; Johansson A; Sonestedt E; Acosta S
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013320. PubMed ID: 34986271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.
    Schmidt AF; Pearce LS; Wilkins JT; Overington JP; Hingorani AD; Casas JP
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011748. PubMed ID: 28453187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statins for the primary prevention of cardiovascular disease.
    Taylor F; Ward K; Moore TH; Burke M; Davey Smith G; Casas JP; Ebrahim S
    Cochrane Database Syst Rev; 2011 Jan; (1):CD004816. PubMed ID: 21249663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.
    Bahiru E; de Cates AN; Farr MR; Jarvis MC; Palla M; Rees K; Ebrahim S; Huffman MD
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD009868. PubMed ID: 28263370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrates for primary prevention of cardiovascular disease events.
    Jakob T; Nordmann AJ; Schandelmaier S; Ferreira-González I; Briel M
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009753. PubMed ID: 27849333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibrates for secondary prevention of cardiovascular disease and stroke.
    Wang D; Liu B; Tao W; Hao Z; Liu M
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009580. PubMed ID: 26497361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Internet-based interventions for the secondary prevention of coronary heart disease.
    Devi R; Singh SJ; Powell J; Fulton EA; Igbinedion E; Rees K
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009386. PubMed ID: 26691216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction in saturated fat intake for cardiovascular disease.
    Hooper L; Martin N; Abdelhamid A; Davey Smith G
    Cochrane Database Syst Rev; 2015 Jun; (6):CD011737. PubMed ID: 26068959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Omega-3 fatty acid supplementation for cystic fibrosis.
    Watson H; Stackhouse C
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluvastatin for lowering lipids.
    Adams SP; Sekhon SS; Tsang M; Wright JM
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012282. PubMed ID: 29508377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low glycaemic index diets for the prevention of cardiovascular disease.
    Clar C; Al-Khudairy L; Loveman E; Kelly SA; Hartley L; Flowers N; Germanò R; Frost G; Rees K
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004467. PubMed ID: 28759107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid-lowering efficacy of atorvastatin.
    Adams SP; Tsang M; Wright JM
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008226. PubMed ID: 25760954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Total red meat intake of ≥0.5 servings/d does not negatively influence cardiovascular disease risk factors: a systemically searched meta-analysis of randomized controlled trials.
    O'Connor LE; Kim JE; Campbell WW
    Am J Clin Nutr; 2017 Jan; 105(1):57-69. PubMed ID: 27881394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomised trial of coconut oil, olive oil or butter on blood lipids and other cardiovascular risk factors in healthy men and women.
    Khaw KT; Sharp SJ; Finikarides L; Afzal I; Lentjes M; Luben R; Forouhi NG
    BMJ Open; 2018 Mar; 8(3):e020167. PubMed ID: 29511019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors.
    Klupp NL; Chang D; Hawke F; Kiat H; Cao H; Grant SJ; Bensoussan A
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD007259. PubMed ID: 25686270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.
    Izquierdo-Palomares JM; Fernandez-Tabera JM; Plana MN; Añino Alba A; Gómez Álvarez P; Fernandez-Esteban I; Saiz LC; Martin-Carrillo P; Pinar López Ó
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009462. PubMed ID: 27888640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pitavastatin for lowering lipids.
    Adams SP; Alaeiilkhchi N; Wright JM
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012735. PubMed ID: 32557581
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.